Evaluation of Cushing's disease remission after transsphenoidal surgery based on early serum cortisol dynamics
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Objective: To evaluate the ability of post‐transsphenoidal pituitary surgery (TSS) serum cortisol levels (s‐cortisol) to predict surgical remission and recurrence of C ushing's disease (CD). Design: One hundred and three patients with CD from a tertiary referral centre were prospectively analysed over 6·0 ± 4·8 years of follow‐up. Twenty patients received perioperative glucocorticoids as routine care and had s‐cortisol measured 10–12 days after TSS (P rotocol I). Eighty‐six patients (91 surgeries) had s‐cortisol measured at 6, 12, 18, 24, 48 h, and 10–12 days after TSS, and received glucocorticoids only in case of adrenal insufficiency (P rotocol II). Main outcomes: Remission [clinical signs and symptoms of adrenal insufficiency (or hypocortisolism) plus cortisol <3 μg/dl on the 1‐mg overnight test (OT) and/or normal free urinary cortisol] during follow‐up. Recurrence was defined as loss of remission criteria at least 1 year after TSS. Results: The remission rate after first TSS was 80%; 8% had recurrence. An s‐cortisol nadir ≤3·5 μg/dl within 48 h after TSS had sensitivity of 73%, specificity and positive predictive value (PPV) of 100% and negative predictive value (NPV) of 60% and an s‐cortisol nadir ≤5·7 μg/dl within 10–12 days of TSS had specificity and PPV of 100% and sensitivity of 91% NPV of 78% for CD remission. Conclusion: At hospital discharge, the s‐cortisol nadir within 48 h after TSS was already able to predict surgical remission for some patients, and the s‐cortisol nadir within 10–12 days of TSS was able to predict cohort‐wide surgical remission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement
Biller, B. M. K., Grossman, A. B., Stewart, P. M., Melmed, S., Bertagna, X., Bertherat, J., Buchfelder, M., Colao, A., Hermus, A. R., Hofland, L. J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2734 · Cited by 853
Diagnosis and Management of Cushing’s Syndrome: Results of an Italian Multicentre Study 1
Invitti, C., Giraldi, F. P., De Martin, M., & Cavagnini, F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5465 · Cited by 336
Cited by
Cushing's disease: pathobiology, diagnosis, and management
Lonser, R. R., Nieman, L., & Oldfield, E. H. (2017) · Journal of Neurosurgery · doi:10.3171/2016.1.jns152119 · Cited by 215
Berr, C. M., Di Dalmazi, G., Osswald, A., Ritzel, K., Bidlingmaier, M., Geyer, L. L., Treitl, M., Hallfeldt, K., Rachinger, W., Reisch, N., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3632 · Cited by 99
“Median urinary cortisol at diagnosis, g/d 50–150 506 (70) 520 (43) 333 (20) 944 (7) .”
Fleseriu, M., Hamrahian, A. H., Hoffman, A. R., Kelly, D. F., & Katznelson, L. (2016) · Endocrine Practice · doi:10.4158/ep161512.dscr · Cited by 68
Nishioka, H., & Yamada, S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111951 · Cited by 65
“Over the years, different centers have used different criteria, as follows: (1) low immediate postoperative serum cortisol [157,158] and ACTH [159], (2) low immediate 24-hour urine free cortisol (UFC) [160], (3) need for glucocorticoid (GC) replacement [160], (4) absence of cortisol/ACTH response to CRH or DDAVP [161–…”
Tabarin, A., Assié, G., Barat, P., Bonnet, F., Bonneville, J. F., Borson-Chazot, F., Bouligand, J., Boulin, A., Brue, T., Caron, P., et al. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.02.001 · Cited by 59
Metadata
- Authors
- Costenaro, F., Rodrigues, T. C., Rollin, G. A. F., Ferreira, N. P., & Czepielewski, M. A.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2013-09-04
- Volume
- 80
- Issue
- 3
- Pages
- 411-418
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2034222913
- Cited by
- 56
- References
- 2
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.